Gene · 3003
NIH grants2,103
NIH grants whose papers are about the gene, through NIH's grant-paper links.
401 to 420 of 2,103
Download this page as JSON| Grant | Title | GZMK papers | Newest fiscal year |
|---|---|---|---|
| R33HL151254 | Medications for Obstructive Sleep Apnea to Improve Cognition in Children with Down Syndrome (MOSAIC DS) | 1 | 2025 |
| R35CA197616 | Advancing Cancer Therapy through Groundbreaking Research in Radiation Biology | 1 | 2025 |
| R35CA197695 | Translating genomic discoveries to improved outcomes for high risk acute leukemia | 1 | 2025 |
| R35CA210087 | Human natural killer cells: Advancing biology and clinical applications | 1 | 2025 |
| R35CA210098 | Overcoming resistance to anti-PD1 immunotherapy | 1 | 2025 |
| R35CA232130 | Annotating Cancer Biology through Non-Invasive Molecular Imaging | 1 | 2025 |
| R35CA253188 | Integrating systems immunology with immunometabolism and cancer immunity | 1 | 2025 |
| R35CA263816 | Novel therapeutic development for small cell lung cancer | 1 | 2025 |
| R35CA263922 | Interaction between nuclear epigenetic and metabolic pathways in cancer | 1 | 2025 |
| R35GM130587 | Theory and Modeling of Biomolecules and their Interactions | 1 | 2025 |
| R35GM133557 | Folding, Misfolding, and Unfolding: How human 3D genome structure resists, adapts, or succumbs to physical stresses in health and disease | 1 | 2025 |
| R35GM134949 | The functional organization of mammalian membranes | 1 | 2025 |
| R35GM138122 | Novel approaches to improve comprehensive profiling of the epigenome and epitranscriptome | 1 | 2025 |
| R35GM141861 | Manifold representations and active learning for 21 st century biology | 1 | 2025 |
| R35GM142647 | Uncovering the functional diversification mechanisms of transcription factor isoforms involved in stem cell differentiation | 1 | 2025 |
| R35GM142963 | Role of vimentin in mammalian cell motility | 1 | 2025 |
| R35GM143072 | An integrative, data-driven, and computational approach to uncovering dynamic mechanisms of early viral infection | 1 | 2025 |
| R35HL161185 | Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure | 1 | 2025 |
| R35NS105068 | Preclinical development of breakthrough immunotherapy for brain tumors | 1 | 2025 |
| R35NS127083 | Contribution of Myeloid-Derived Suppressor Cells to Neuro-Inflammatory Alterations and Disease Progression in Glioblastoma | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/grants?page=21